Biography
Dr. Paul Mansfield is a Professor of Surgical Oncology at MD Anderson Cancer Center in Houston, Texas, where he serves as the program's lead surgeon for peritoneal mesothelioma. He performs cytoreductive surgery with HIPEC and has extensive experience treating peritoneal surface malignancies at the nation's top-ranked cancer hospital. Dr. Mansfield trained in surgical oncology at the National Cancer Institute and has built decades of expertise in the surgical management of peritoneal cancers. His position at MD Anderson provides patients access to a comprehensive multidisciplinary team and clinical trial opportunities that are available at few other institutions.
Education & Training
- Medical Degree — Jefferson Medical College (Medicine)
- Residency — Pennsylvania Hospital (General Surgery)
- Fellowship — National Cancer Institute (Surgical Oncology)
Specialties & Procedures
Clinical Specialties
- Surgical Oncology
- Peritoneal Surface Malignancies
- HIPEC
Surgical Procedures
Board Certifications
- American Board of Surgery
Research Focus
Peritoneal mesothelioma surgical treatment, cytoreductive surgery with HIPEC, and outcomes research for peritoneal surface malignancies.
Treatment Center
Dr. Paul Mansfield practices at MD Anderson Cancer Center in Houston, TX.
Legal Resources for Mesothelioma Patients
Patients diagnosed with mesothelioma after asbestos exposure may be eligible for compensation through asbestos trust funds and legal claims. Over $30 billion remains available in trust funds nationwide.
Frequently Asked Questions
Does MD Anderson have a peritoneal mesothelioma program?
Yes. Dr. Mansfield leads the peritoneal mesothelioma surgical program at MD Anderson, performing cytoreductive surgery with HIPEC as part of a comprehensive multidisciplinary approach at the nation's top-ranked cancer center.